These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24602414)

  • 1. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-221 and -222 pathway controls melanoma progression.
    Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
    Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
    Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-mediated regulation of melanoma.
    Sun V; Zhou WB; Majid S; Kashani-Sabet M; Dar AA
    Br J Dermatol; 2014 Aug; 171(2):234-41. PubMed ID: 24665835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma genetics: the other side.
    Bis S; Tsao H
    Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression signatures in solid malignancies.
    Galasso M; Sandhu SK; Volinia S
    Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
    Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
    Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
    Wozniak M; Mielczarek A; Czyz M
    Curr Med Chem; 2016; 23(28):3136-3153. PubMed ID: 27666934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
    Mishra RR; Kneitz S; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
    Zhang Z; Zhang S; Ma P; Jing Y; Peng H; Gao WQ; Zhuang G
    Carcinogenesis; 2015 Sep; 36(9):937-45. PubMed ID: 26071398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA in non-melanoma skin cancer.
    Sand M; Sand D; Altmeyer P; Bechara FG
    Cancer Biomark; 2012; 11(6):253-7. PubMed ID: 23248183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
    Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers in melanoma.
    Kashani-Sabet M
    Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.